Shares of Evoke plc (LON:EVOK – Get Free Report) dropped 10% during mid-day trading on Thursday . The company traded as low as GBX 50.20 ($0.65) and last traded at GBX 51.73 ($0.67). Approximately 65,066,164 shares traded hands during mid-day trading, an increase of 1,994% from the average daily volume of 3,107,171 shares. The stock had previously closed at GBX 57.45 ($0.74).
Analyst Upgrades and Downgrades
Several equities analysts have recently issued reports on the company. Berenberg Bank decreased their price objective on Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a “buy” rating for the company in a research note on Wednesday, December 4th. Jefferies Financial Group reiterated a “buy” rating and set a GBX 140 ($1.81) price target on shares of Evoke in a report on Monday, December 16th.
Read Our Latest Stock Report on Evoke
Evoke Trading Down 1.1 %
Evoke (LON:EVOK – Get Free Report) last announced its quarterly earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) earnings per share (EPS) for the quarter. Evoke had a negative net margin of 8.50% and a negative return on equity of 517.98%. As a group, equities research analysts predict that Evoke plc will post 12.7648305 EPS for the current year.
Insider Activity
In related news, insider Andrea Gisle Joosen purchased 14,572 shares of Evoke stock in a transaction that occurred on Tuesday, January 28th. The stock was purchased at an average cost of GBX 70 ($0.91) per share, with a total value of £10,200.40 ($13,202.69). Company insiders own 27.00% of the company’s stock.
About Evoke
Featured Articles
- Five stocks we like better than Evoke
- Earnings Per Share Calculator: How to Calculate EPS
- MarketBeat Week in Review – 03/24 – 03/28
- How to Calculate Return on Investment (ROI)
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Evoke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke and related companies with MarketBeat.com's FREE daily email newsletter.